کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1928065 | 1050309 | 2015 | 7 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: MicroRNA-378 regulates neural stem cell proliferation and differentiation in vitro by modulating Tailless expression MicroRNA-378 regulates neural stem cell proliferation and differentiation in vitro by modulating Tailless expression](/preview/png/1928065.png)
• miR-378 targeted and regulated TLX.
• miR-378 was increased during NSC differentiation.
• miR-378 regulated NSC proliferation and differentiation.
• miR-378 regulated NSC self-renew through TLX.
Previous studies have suggested that microRNAs (miRNAs) play an important role in regulating neural stem cell (NSC) proliferation and differentiation. However, the precise role of miRNAs in NSC remains largely unexplored. In this study, we showed that miR-378 can target Tailless (TLX), a critical regulator of NSC, to regulate NSC proliferation and differentiation. By bioinformatic algorithms, miR-378 was found to have a predicted target site in the 3′-untranslated region of TLX, which was verified by a dual-luciferase reporter assay. The expression of miR-378 was increased during NSC differentiation and inversely correlated with TLX expression. qPCR and Western blot analysis also showed that miR-378 negatively regulated TLX mRNA and protein expression in neural stem cells (NSCs). Intriguingly, overexpression of miR-378 increased NSC differentiation and reduced NSC proliferation, whereas suppression of miR-378 led to decreased NSC differentiation and increased NSC proliferation. Moreover, the downstream targets of TLX, including p21, PTEN and Wnt/β-catenin were also found to be regulated by miR-378. Additionally, overexpression of TLX rescued the NSC proliferation deficiency induced by miR-378 overexpression and abolished miR-378-promoted NSC differentiation. Taken together, our data suggest that miR-378 is a novel miRNA that regulates NSC proliferation and differentiation via targeting TLX. Therefore, manipulating miR-378 in NSCs could be a novel strategy to develop novel interventions for the treatment of relevant neurological disorders.
Journal: Biochemical and Biophysical Research Communications - Volume 466, Issue 2, 16 October 2015, Pages 214–220